Am I a biohazard?

By Daniel Grushkin Am I a biohazard? Foreign genes expressed in glowing E. coli, the result of the evening’s DIYbio experiment. Courtesy of Ellen Jorgensen Brooklyn, New York, April 21, 19:00 hours: Molecular biologist Ellen Jorgensen and I spread a plastic tarp over my cherry table and parquet floor. Then, one by one, we set vials and pipettes down, preparing a lab in my living room. We had dubbed it DNA and P

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Brooklyn, New York, April 21, 19:00 hours: Molecular biologist Ellen Jorgensen and I spread a plastic tarp over my cherry table and parquet floor. Then, one by one, we set vials and pipettes down, preparing a lab in my living room. We had dubbed it DNA and Pizza Night on the DIYbio message board, inviting aspiring amateur geneticists to gather and learn the rudiments of bioengineering. Not a bad deal either—a lab followed by beer and pizza, all for $10 per person.

As the aficionados and the curious made their way to my Brooklyn home, Jorgensen and I laid out our genetic-makeover patient, a sealed Petri dish of E. coli. It was our first meeting working with live bacteria, and it had already taken on an illicit air.

The People's Lab

Brick by Brick

Standardize What?

In May, The Wall Street Journal asked whether amateur gatherings like ours were “a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Daniel Grushkin

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo